HHS/CMS Drugs pricing negotiation. August 2023 . . . HHS announced they would negotiate the pricing for 10 drugs covered under Medicare Part D program. This was the first cycle of selected drugs to be negotiated by the U.S. Department of Health and Human Services or HHS as many know it. The first cycle of negotiations, with […]

A follow-up to the much longer report on Insulin (test on this later) and how PBMs impact pricing on other drugs. “Insulin A Drug Pricing Analysis,” Angry Bear. “Drug manufacturers alone set and raise drug prices, and PBMs are holding drug companies accountable by negotiating the lowest possible cost for drugs, including insulins, on behalf […]

I have been thinking about buprenorphine, naltrexone and the stimulants cocaine and methamphetamine. An issue which came to my mind recently and which I think it worth discussing is that cocaine is often cut and replaced with fentanyl to hide the over-dilution. This is sometimes done sloppily leading to fentanyl overdoses of people who did […]

AB: It is a government policy to turn the fruits of its research over to private industry without any strings attached. The 1980 Bayh-Dole Act allows the National Institutes of Health (NIH) and universities housing government-funded scientists to patent and transfer (for royalties, of course) their scientific discoveries, research tools, and drug candidates to private […]

I was looking for information on drug related murders and inadvertently stumbled on this old Bureau of Justice of Statistics report. There’s a lot of interesting information in it. One fascinating table is this: For context, here is the population breakdown over a period that includes the timespan in the table. I’m not sure this […]